医保发〔2025〕16号
Notice of the National Healthcare Security Administration and the National Health Commission on Issuing the Several Measures to Support High-Quality Development of Innovative Drugs
国家医保局 国家卫生健康委关于印发《支持创新药高质量发展的若干措施》的通知
Instrument
policy issuance
This document jointly issued by the National Healthcare Security Administration and the National Health Commission outlines policy measures to promote the high-quality development of innovative drugs, including regulatory support, reimbursement mechanisms, and industry incentives.